BALTIMORE — Lupin has launched its Clobetasol Propionate Topical Solution USP, 0.05%.
Clobetasol is the generic equivalent of Fougera Pharmaceuticals’ Temovate (clobetasol propionate) Scalp Application, 0.05%. It is indicated for short-term topical treatment of inflammatory and pruritic manifestations of moderate to severe corticosteroid-responsive dermatoses of the scalp.
Temovate Clobetasol Propionate Scalp Application had an estimated U.S. sales of USD 64.1 million in 2016.
March 7, 2017 | By Brian Berk